Organic Vaccines Plc - Agreements With NIH And National Cancer Institute
PARIS, November 17, 2014 /PRNewswire/ --
On July 7th and September 3rd 2014, Organic Vaccines LLC, a 98% held subsidiary of Organic Vaccines Plc, has entered into a commercial evaluation license agreement with the US National Institutes of Health and a three-year collaborative agreement with the US National Cancer Institute, with a principal goal of developing human monoclonal antibody-based techniques targeting the Middle East Respiratory Syndrome Coronovirus (MERS-CoV).
To view the Multimedia News Release, please click: http://www.multivu.com/players/English/72762588-organic-vaccines-MERS-CoV/
Patrick Rambaud, President and CEO of Organic Vaccines Plc commented: "These agreements shall enable OV to complement its strategy against MERS CoV. During our meeting of September 18th at the control and command center of the Ministry of Health in Jeddah (Saudi Arabia), we have explained the science and exposed our strategy. Our objective is to be at the earliest in a position to offer a stopgap treatment on a compassionate basis. We have already started complementary studies to meet WHO requirements and submit our dossier."
Organic Vaccines Plc
Organic Vaccines Plc is a biopharmaceutical company focusing on the development of preventive and therapeutic vaccines produced using the patient's own white blood cells. Areas of vaccine development cover children vaccines, flu vaccines and HPV adult vaccines (preventive and therapeutic) as well as the implementation of white blood cell banks. Vaccines should avoid side effects and will be developed using the AAPC technology (artificial antigen presenting cells). Organic Vaccines' scientific team is a world renowned team of scientists, including Prof. Bruce Beutler (2011 Nobel Prize).
Organic Vaccines is listed on the French Alternativa SME stock market (http://www.alternativa.fr).
Organic Vaccines is represented in KSA by Tharaa Global Holding Co
For further information
http://www.organic-vaccines.com
Video:
http://www.multivu.com/players/English/72762588-organic-vaccines-MERS-CoV/
Help employers find you! Check out all the jobs and post your resume.
On July 7th and September 3rd 2014, Organic Vaccines LLC, a 98% held subsidiary of Organic Vaccines Plc, has entered into a commercial evaluation license agreement with the US National Institutes of Health and a three-year collaborative agreement with the US National Cancer Institute, with a principal goal of developing human monoclonal antibody-based techniques targeting the Middle East Respiratory Syndrome Coronovirus (MERS-CoV).
To view the Multimedia News Release, please click: http://www.multivu.com/players/English/72762588-organic-vaccines-MERS-CoV/
Patrick Rambaud, President and CEO of Organic Vaccines Plc commented: "These agreements shall enable OV to complement its strategy against MERS CoV. During our meeting of September 18th at the control and command center of the Ministry of Health in Jeddah (Saudi Arabia), we have explained the science and exposed our strategy. Our objective is to be at the earliest in a position to offer a stopgap treatment on a compassionate basis. We have already started complementary studies to meet WHO requirements and submit our dossier."
Organic Vaccines Plc
Organic Vaccines Plc is a biopharmaceutical company focusing on the development of preventive and therapeutic vaccines produced using the patient's own white blood cells. Areas of vaccine development cover children vaccines, flu vaccines and HPV adult vaccines (preventive and therapeutic) as well as the implementation of white blood cell banks. Vaccines should avoid side effects and will be developed using the AAPC technology (artificial antigen presenting cells). Organic Vaccines' scientific team is a world renowned team of scientists, including Prof. Bruce Beutler (2011 Nobel Prize).
Organic Vaccines is listed on the French Alternativa SME stock market (http://www.alternativa.fr).
Organic Vaccines is represented in KSA by Tharaa Global Holding Co
For further information
http://www.organic-vaccines.com
Video:
http://www.multivu.com/players/English/72762588-organic-vaccines-MERS-CoV/
Help employers find you! Check out all the jobs and post your resume.